These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 27152469
1. Validation of TURN, a simple predictor of symptomatic intracerebral hemorrhage after IV thrombolysis. Asuzu D, Nystrӧm K, Amin H, Schindler J, Wira C, Greer D, Chi NF, Halliday J, Sheth KN. Clin Neurol Neurosurg; 2016 Jul; 146():71-5. PubMed ID: 27152469 [Abstract] [Full Text] [Related]
2. TURN: A Simple Predictor of Symptomatic Intracerebral Hemorrhage After IV Thrombolysis. Asuzu D, Nyström K, Amin H, Schindler J, Wira C, Greer D, Chi NF, Halliday J, Sheth KN. Neurocrit Care; 2015 Oct; 23(2):166-71. PubMed ID: 25869481 [Abstract] [Full Text] [Related]
8. Cohort-Based Identification of Predictors of Symptomatic Intracerebral Hemorrhage After IV Thrombolysis. Asuzu D, Nyström K, Amin H, Schindler J, Wira C, Greer D, Chi NF, Halliday J, Sheth KN. Neurocrit Care; 2015 Dec; 23(3):394-400. PubMed ID: 25691004 [Abstract] [Full Text] [Related]
9. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models. Li M, Wang-Qin RQ, Wang YL, Liu LB, Pan YS, Liao XL, Wang YJ, Xu AD. J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755 [Abstract] [Full Text] [Related]
10. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC, Rabinstein AA. Cerebrovasc Dis; 2012 Jun; 34(2):106-14. PubMed ID: 22868870 [Abstract] [Full Text] [Related]
11. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1). Charidimou A, Pasi M, Fiorelli M, Shams S, von Kummer R, Pantoni L, Rost N. Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738 [Abstract] [Full Text] [Related]
12. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment. Vandelli L, Marietta M, Trenti T, Varani M, Bigliardi G, Rosafio F, Dell'acqua ML, Picchetto L, Nichelli P, Zini A. Adv Clin Exp Med; 2019 Feb; 28(2):219-222. PubMed ID: 30507073 [Abstract] [Full Text] [Related]
13. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis. Tanaka K, Matsumoto S, Furuta K, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI. J Thromb Thrombolysis; 2020 Jul; 50(1):174-180. PubMed ID: 31745858 [Abstract] [Full Text] [Related]
14. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators. Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [Abstract] [Full Text] [Related]
15. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage. Gumbinger C, Gruschka P, Böttinger M, Heerlein K, Barrows R, Hacke W, Ringleb P. Stroke; 2012 Jan; 43(1):240-2. PubMed ID: 21998049 [Abstract] [Full Text] [Related]
16. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China). Fan Y, Liao X, Pan Y, Dong K, Wang Y, Wang Y, Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China) InvestigatorsDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China; Department of Neurology, Baotou Central Hospital, Baotou, Inner Mongolia, China.. J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863 [Abstract] [Full Text] [Related]
17. Safety of routine IV thrombolysis between 3 and 4.5 h after ischemic stroke. Uyttenboogaart M, Vroomen PC, Stewart RE, De Keyser J, Luijckx GJ. J Neurol Sci; 2007 Mar 15; 254(1-2):28-32. PubMed ID: 17257623 [Abstract] [Full Text] [Related]
18. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study. Sørensen SB, Barazangi N, Chen C, Wong C, Grosvenor D, Rose J, Bedenk A, Morrow M, McDermott D, Hove JD, Tong DC. J Stroke Cerebrovasc Dis; 2016 May 15; 25(5):1110-1118. PubMed ID: 26897101 [Abstract] [Full Text] [Related]
19. Risk rtPA: An iOS mobile application based on TURN for predicting 90-day outcome after IV thrombolysis. Asuzu D, Nystrӧm K, Schindler J, Wira C, Greer D, Halliday J, Sheth KN. Clin Neurol Neurosurg; 2016 Mar 15; 142():148-152. PubMed ID: 26875069 [Abstract] [Full Text] [Related]
20. Risk of symptomatic intracerebral hemorrhage after thrombolysis with rt-PA: the SEDAN score. Brüning T, Al-Khaled M. CNS Neurosci Ther; 2015 Mar 15; 21(3):296-7. PubMed ID: 25622691 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]